Page 16 - Addiction and Overdose: Confronting an American Crisis
P. 16

demographics of, 37–43        Suboxone, 89–91, 94
              emergency treatment for, 44–46, 59–61  Substance Abuse and Mental Health Services
              as epidemic, 68–69               Administration (SAMHSA), 48, 83, 102
              family stories, 4–8, 12–13, 22–23, 53, 59–61  substance use disorder, 24, 26, 42
              increase in the United States, 5–7, 56–58, 69  Subutex, 89
            over-the-counter drugs (OTC), 70  See also buprenorphine
              acetaminophen, 9, 76          synapses, 16–17
            oxycodone, 11, 23, 36           synthetic stimulants, 11
            OxyContin, 9, 11, 40, 42, 48, 54–55, 58
            oxymorphone, 37, 74             teens and addiction, 25–30, 31–32, 57, 59
            oxytocin, 18                    toxicology reports, 12
                                            treatment programs
            Percocet, 5, 11, 32, 42          culturally appropriate models, 83
            Percodan, 11, 35                 day treatment, 83, 86
            Phoenix House, 34                emergency room, 47
            Physicians for Responsible Opioid Prescribing, 34  faith-based models, 82–83, 103
            pill mills, 74                   inpatient, 46, 82–85
            prescription painkillers, 9–13, 20, 23–26, 29–30,   long-term residential, 85
               32–34, 36–37, 42–45, 50, 54–56, 65,   medication-assisted treatment, 88, 90–94
               74, 92                        outpatient, 85–86, 88
              See also opioids               self-help groups, 15–16, 46, 86–87
            prescription tranquilizers, 44   short-term residential, 86
            Probuphine, 89                   stories of success, 33, 82, 102
              See also buprenorphine        twelve-step programs, 101, 103
            Providence Crosstown Clinic, 95–98  Alcoholics Anonymous, 15, 86–87
            Prozac, 11                       Narcotics Anonymous, 46, 86–87
            PZM21, 92
                                            US Department of Health and Human Services,
            racial stereotyping, 38            62–63
            recovery programs.              US Drug Enforcement Administration (DEA), 4, 13,
              See treatment programs           31, 56, 72
            rehabilitation programs, 34, 42, 46, 83, 84–86,   US Treasury Department’s Narcotic Division, 61
               88–91, 97
            relapse, 15, 36, 42, 88, 90, 93, 100–102  Valium, 5, 9, 11
            reward pathways. See neurology  Vicodin, 5, 9, 11, 32, 35, 43–44, 48
            Roxanol, 11                     Vivitrol, 90
                                             See also naltrexone
            scientists and researchers, 17–20, 22, 68, 92
            sedatives, 47                   White House Office of National Drug Control Policy,
              Ativan, 9                        99
              Valium, 5, 9, 11              withdrawal, 24, 33, 36, 42, 58, 62–65, 85, 88–93
              Xanax, 9, 53                   symptoms, 22
            self-medicating                 withdrawal medications, 102
              and addiction, 37              buprenorphine, 89–90, 93–95, 102
            serotonin, 18                    methadone, 65, 88–89, 91, 93–95
            Shine a Light on Heroin, 105     naltrexone, 90
            sobriety, 82–83, 86–87, 101–102  Suboxone, 89–91, 94
            stimulant overdose, 47          Xanax, 9, 53
            stimulants
              cocaine, 11, 44, 47           Zohydro, 11, 48
              methamphetamine, 11, 44, 47   Zoloft, 11





     126
   11   12   13   14   15   16   17   18